Performance Contribution

Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Woodford Patient Capital Trust plc

Home > Funds > Woodford Patient Capital Trust plc > Performance Contribution

We recognise that openness and transparency are key in building client understanding and we ensure that our clients get unprecedented levels of clear and relevant information about their investments, including unparalleled access to our Investment team and transparency into our portfolio construction and performance contribution.

To keep our investors informed, we are committed to providing full disclosure of the performance contribution of the Woodford Patient Capital Trust’s holdings on a quarterly basis.

Please find the performance contribution of the portfolio holdings below.

The details set out are for information purposes only. Care is taken in ensuring this is accurate as at the stated date. However, this is not guaranteed and the portfolio may change at any time and listed holdings may no longer be represented in the trust. This does not constitute investment advice or any recommendation with regard to the listed stocks.

Performance contribution

Source: Financial Express, Woodford, as at 30 September 2017

Full portfolio contribution

1 year to 30 September 2017
Stock Sector Country Stock return (%) Average weight (%) Contribution (%)
Purplebricks Financials United Kingdom 193.73 7.27 6.77
Immunocore Health Care United Kingdom 40.33 6.20 2.18
Oxford Nanopore Health Care United Kingdom 34.61 7.65 2.00
Kymab Health Care United Kingdom -- 2.51 0.99
Horizon Discovery Health Care United Kingdom 55.35 1.70 0.96
Ultrahaptics Technology United Kingdom -- 1.40 0.96
Prothena Health Care United States 4.56 15.30 0.74
Gigaclear Telecommunications United Kingdom 33.20 2.11 0.64
Oxford Sciences Innovation Financials United Kingdom 20.00 3.28 0.61
Proton Partners International Health Care United Kingdom 15.00 4.11 0.59
Alkermes Health Care United States -- 0.39 0.44
Precision Biopsy Health Care United States 35.51 1.00 0.42
A J Bell Financials United Kingdom 39.80 1.13 0.38
Silence Therapeutics Health Care United Kingdom 58.98 0.56 0.33
Atom Bank Financials United Kingdom 15.00 2.41 0.28
Eve Sleep Consumer Goods United Kingdom -- 0.57 0.23
Mereo Biopharma Health Care United Kingdom 5.13 4.02 0.21
PsiOxus Health Care United Kingdom 72.50 0.30 0.17
Xeros Industrials United Kingdom 12.14 1.11 0.15
Seedrs Financials United Kingdom 13.65 0.73 0.09
Utilitywise Industrials United Kingdom -- 0.50 0.05
Arix Bioscience Financials United Kingdom -- 1.73 0.04
Tissue Regenix Health Care United Kingdom -- 0.08 0.04
Abzena Health Care United Kingdom -16.68 0.48 0.03
Draper Esprit Financials United Kingdom 0.83 0.81 0.00
Cell Medica Health Care United Kingdom -- 0.59 0.00
Cambridge Innovation Capital Financials United Kingdom 0.00 0.25 0.00
Mission Therapeutics Health Care United Kingdom 0.00 0.70 0.00
Accelerated Digital Ventures Financials United Kingdom -- 0.22 0.00
Inivata Health Care United Kingdom 0.00 0.80 0.00
Benevolent AI Technology United Kingdom 0.00 1.13 0.00
Novabiotics Health Care United Kingdom -- 0.18 0.00
Yoyo Wallet Technology United Kingdom -- 0.00 0.00
Dementia Discovery Fund Health Care United Kingdom -- 0.05 0.00
Fibre 7 Industrials United Kingdom -- 0.18 0.00
Ratesetter Financials United Kingdom -- 0.18 0.00
Econic Industrials United Kingdom 0.00 0.20 0.00
American Financial Exchange Financials United States -3.18 0.19 -0.01
Midatech Pharma Health Care United Kingdom -- 0.01 -0.01
Mafic Industrials Luxembourg -3.18 0.58 -0.02
AMO Pharma Health Care United Kingdom -3.18 0.97 -0.03
SciFluor Life Sciences Health Care United States -3.18 1.10 -0.04
Metalysis Industrials United Kingdom -8.35 0.71 -0.06
Halosource Industrials United Kingdom -80.77 0.09 -0.08
Nexeon Industrials United Kingdom -12.50 0.65 -0.08
Circassia Health Care United Kingdom -- 1.19 -0.09
Origin Health Care United States -- 0.18 -0.12
Itaconix Basic Materials United Kingdom -32.76 0.34 -0.13
Federated Wireless Technology United States -- 0.66 -0.14
Verseon Health Care United Kingdom -21.09 1.49 -0.20
Autolus Health Care United Kingdom 46.15 0.97 -0.21
Northwest Biotherapeutics Health Care United States -68.34 0.19 -0.23
Oxford Pharmascience Health Care United Kingdom -50.48 0.35 -0.24
Theravance Biopharma Health Care United States -8.25 5.01 -0.24
Hvivo Health Care United Kingdom -- 0.29 -0.24
Mercia Technologies Financials United Kingdom -35.63 0.77 -0.34
Benchmark Health Care United Kingdom -41.46 1.18 -0.34
Sphere Medical Health Care United Kingdom -96.60 0.25 -0.39
Evofem Health Care United States -- 0.37 -0.40
IP Group Financials United Kingdom -- 1.33 -0.43
Drayson Technologies C Technology United Kingdom -- 1.22 -0.44
Thin Film Electronics Industrials Norway -- 1.00 -0.46
Malin Financials Ireland -15.15 2.20 -0.49
Netscientific Health Care United Kingdom -46.13 0.79 -0.50
Idex Technology Norway -19.83 2.48 -0.54
Cequr Health Care Switzerland -35.59 1.08 -0.56
ReNeuron Health Care United Kingdom -35.24 1.34 -0.57
Ombu Financials United Kingdom -- 1.70 -0.57
Touchstone Innovations Financials United Kingdom -29.96 1.74 -0.86
RM2 International 9% convertible Industrials United Kingdom -- 0.71 -1.19
Kind Consumer Consumer Goods United Kingdom -- 0.90 -1.29
Industrial Heat Industrials United Kingdom -- 1.65 -1.38
Vernalis Health Care United Kingdom -65.48 1.29 -1.41
Allied Minds Financials United Kingdom -58.62 2.21 -1.63
4D Pharma Health Care United Kingdom -53.43 2.20 -1.98

Source: Northern Trust

Performance contributions are calculated on a total return basis, including the impact of intra-period trading, gross of fees in sterling using closing prices. Contribution totals may therefore not match fund performance data from other data sources which may be based on midday prices, net of fees. Values do not always sum due to rounding. Stock returns can only be calculated where the position has been held by the fund for the full period. Individual securities which relate to the same holding have been aggregated together where appropriate.

Past performance is not a guide to future returns. This data is provided for information purposes only and should not be reproduced, published or disseminated in any manner. Care is taken in ensuring this is accurate as at the stated date. However, this is not guaranteed, and the portfolio may change at any time. This does not constitute investment advice or any recommendation with regard to the listed stocks.

What are the risks?

  • The value of the fund and any income from it may go down as well as up, so you may get back less than you invested
  • Past performance cannot be relied upon as a guide to future performance
  • The annual management charge is charged to capital, so the income of the fund may be higher but capital growth may be restricted or capital may be eroded
  • The fund may invest in other transferable securities, money market instruments, warrants, collective investment schemes and deposits
  • The fund may invest in overseas securities and be exposed to currencies other than pound sterling
  • The fund may invest in unquoted securities, which may be less liquid and more difficult to realise than publicly traded securities

Important information

Before investing, you should read the Key Investor Information Document (KIID) for the fund, and the Prospectus which, along with our terms and conditions, can be obtained from the downloads page or from our registered office. If you have a financial adviser, you should seek their advice before investing. Woodford Investment Management Ltd is not authorised to provide investment advice.

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address Beaufort House, 51 New North Road, Exeter, EX4 4EP.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland, Tel: +41 21 311 17 77, email: info@oligofunds.ch. The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at www.fundinfo.com.

© 2017 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement